Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New horizons in the diagnosis and management of Alzheimer's Disease in older adults.

Age and ageing - 1 Feb 2024

Dolphin Helena, Dyer Adam H, Morrison Laura, Shenkin Susan D, Welsh Tomas, Kennelly Sean P

Abstract excerpt

Alzheimer's Disease (ad) is the most common cause of dementia, and in addition to cognitive decline, it directly contributes to physical frailty, falls, incontinence, institutionalisation and polypharmacy in older adults. Increasing availability of clinically validated biomarkers including cerebrospinal fluid and positron emission tomography to assess both amyloid and tau pathology has led to a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alzheimer Disease
Share to Amyloid beta-Peptides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Cognitive Dysfunction

Share to Phenotype

Share to Positron-Emission Tomography

Source

Open in PubMed Open full text

Identifiers

PMID: 38342754
DOI: 10.1093/ageing/afae005
PMCID: PMC10859247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New horizons in the diagnosis and management of Alzheimer's Disease in older adults.PMID 38342754Read ↗

Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious UpdateSemantic proximity Read ↗

Biomarker-based staging of Alzheimer disease: rationale and clinical applicationsSemantic proximity Read ↗

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.Semantic proximity Read ↗

Alzheimer's disease.Semantic proximity Read ↗

Diagnosis and treatment of Alzheimer's disease.Semantic proximity Read ↗

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.Semantic proximity Read ↗

New insights into atypical Alzheimer's disease in the era of biomarkersSemantic proximity Read ↗

Clinical and pathological examples of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia.Semantic proximity Read ↗

Emerging Biomarkers for Early Detection of Alzheimer’s Disease: A Systematic ReviewSemantic proximity Read ↗

Recent Insights into Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies.Semantic proximity Read ↗

Therapeutic Targets for Alzheimer's Disease: Amyloid Vs. Non-Amyloid. Where Does Consensus Lie Today? An CTAD Task Force ReportSemantic proximity Read ↗

Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.